P2X7 Receptor: A Potential Therapeutic Target for Depression?
Open accessAbstract
Depression is a prime contributor to global disease burden with 300 million affected patients worldwide. The persistent lack of progress with regards to pharmacotherapy stands in stark contrast to the pandemic magnitude of the disease. Alterations of inflammatory pathways in depressed patients, including altered circulating pro-inflammatory cytokines, have been put forward as a potential pathophysiological mechanism. The P2X7 receptor (P2X7R) plays an important role regulating the release of interleukin-1β and other cytokines. Comprehensive investigation of the P2X7R Gln460Arg missense mutation (rs2230912), which has been associated with major depression and bipolar disorder, has substantially contributed to validate P2X7R as a potential genetic risk factor. We propose that P2X7R is a putative target with good prospects for therapeutic intervention in depressive disorders.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Neuroinflammation and increased levels of ATP are observed in neuropsychiatry disorders, supposedly correlated with P2X7 receptor activation.
“Neuroinflammation and increased levels of ATP are observed in neuropsychiatry disorders, supposedly correlated with P2X7 receptor activation [118, 145].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [145]
P2X7R has been suggested as a putative target for therapeutic intervention in mood disorders.
“Among the purinergic receptors, the P2X7R has been suggested as a putative target for therapeutic intervention in mood disorders [33] (Figure 2).”
From P2X7 Receptor Signaling in Stress and Depression (2019) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729 · see citing works
Stress and the brain: from adaptation to disease
de Kloet, E. R., Joëls, M., & Holsboer, F. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1683 · Cited by 4,621 · see citing works
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942 · see citing works
eQTLGen, Wray, N. R., 23andMe, the Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, Ripke, S., Mattheisen, M., Trzaskowski, M., Byrne, E. M., Abdellaoui, A., Adams, M. J., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0090-3 · Cited by 3,005 · see citing works
Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766 · see citing works
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs
Cross-Disorder Group of the Psychiatric Genomics Consortium (2013) · Nature Genetics · doi:10.1038/ng.2711 · Cited by 2,263 · see citing works
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Dinarello, C. A. (2011) · Blood · doi:10.1182/blood-2010-07-273417 · Cited by 2,248 · see citing works
Surprenant, A., Rassendren, F., Kawashima, E., North, R. A., & Buell, G. (1996) · Science · doi:10.1126/science.272.5262.735 · Cited by 1,739 · see citing works
Goldsmith, D. R., Rapaport, M. H., & Miller, B. J. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.3 · Cited by 1,683 · see citing works
New approaches to antidepressant drug discovery: beyond monoamines
Berton, O., & Nestler, E. J. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1846 · Cited by 1,589 · see citing works
Pannexin‐1 mediates large pore formation and interleukin‐1β release by the ATP‐gated P2X7 receptor
Pelegrı́n, P., & Surprenant, A. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601378 · Cited by 1,428 · see citing works
Genetic architectures of psychiatric disorders: the emerging picture and its implications
Sullivan, P. F., Daly, M. J., & O'Donovan, M. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3240 · Cited by 1,177 · see citing works
Altered Cytokine Production in Mice Lacking P2X7Receptors
Solle, M., Labasi, J. M., Perregaux, D. G., Stam, E. J., Petrushova, N., Koller, B. H., Griffiths, R., & Gabel, C. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006781200 · Cited by 924 · see citing works
A Swedish National Twin Study of Lifetime Major Depression
Kendler, K. S., Gatz, M., Gardner, C. O., & Pedersen, N. L. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.109 · Cited by 794 · see citing works
Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain
Chessell, I. P., Hatcher, J. P., Bountra, C., Michel, A. D., Hughes, J. P., Green, P., Egerton, J., Murfin, M., Richardson, J. C., Peck, W. L., et al. (2005) · Pain · doi:10.1016/j.pain.2005.01.002 · Cited by 790 · see citing works
Integrating neuroimmune systems in the neurobiology of depression
Wohleb, E. S., Franklin, T., Iwata, M., & Duman, R. S. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.69 · Cited by 668 · see citing works
Circadian rhythm disturbances in depression
Germain, A., & Kupfer, D. J. (2008) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.964 · Cited by 644 · see citing works
Craddock, N. J., & Sklar, P. B. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60855-7 · Cited by 635 · see citing works
Neuroimmune mechanisms of depression
Hodes, G. E., Kana, V., Menard, C., Merad, M., & Russo, S. J. (2015) · Nature Neuroscience · doi:10.1038/nn.4113 · Cited by 585 · see citing works
Lopez-Munoz, F. J., & Álamo, C. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168001 · Cited by 476 · see citing works
Neuroinflammation and comorbidity of pain and depression
Walker, A. K., Kavelaars, A., Heijnen, C. J., & Dantzer, R. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008144 · Cited by 460 · see citing works
Köhler, C. A., Freitas, T. H., Stubbs, B., Maes, M., Solmi, M., Veronese, N., de Andrade, N. Q., Morris, G., Fernandes, B. S., Brunoni, A. R., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0632-1 · Cited by 449 · see citing works
P2X7 receptor: an emerging target in central nervous system diseases
Sperlágh, B., & Illes, P. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.08.002 · Cited by 390 · see citing works
Iwata, M., Ota, K. T., Li, X.-Y., Sakaue, F., Li, N., Dutheil, S., Banasr, M., Duric, V., Yamanashi, T., Kaneko, K., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.11.026 · Cited by 387 · see citing works
The P2X7 receptor: A main player in inflammation
Adinolfi, E., Giuliani, A. L., De Marchi, E., Pegoraro, A., Orioli, E., & Di Virgilio, F. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.12.021 · Cited by 385 · see citing works
Genome-wide association study reveals two new risk loci for bipolar disorder
Mühleisen, T. W., Leber, M., Schulze, T. G., Strohmaier, J., Degenhardt, F., Treutlein, J., Mattheisen, M., Forstner, A. J., Schumacher, J., Breuer, R., et al. (2014) · Nature Communications · doi:10.1038/ncomms4339 · Cited by 346 · see citing works
Diversity of Transgenic Mouse Models for Selective Targeting of Midbrain Dopamine Neurons
Lammel, S., Steinberg, E. E., Földy, C., Wall, N. R., Beier, K. T., Luo, L., & Malenka, R. C. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.036 · Cited by 345 · see citing works
Anisman, H., Merali, Z., & Hayley, S. P. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.01.004 · Cited by 334 · see citing works
Yue, N., Huang, H., Zhu, X., Han, Q., Wang, Y., Li, B., Liu, Q., Wu, G., Zhang, Y., & Yu, J. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0865-y · Cited by 334 · see citing works
Keystone, E. C., Wang, M. M., Layton, M., Hollis, S., & McInnes, I. B. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-143578 · Cited by 318 · see citing works
Structural basis for subtype-specific inhibition of the P2X7 receptor
Karasawa, A., & Kawate, T. (2016) · eLife · doi:10.7554/elife.22153 · Cited by 308 · see citing works
Wake and sleep EEG provide biomarkers in depression
Steiger, A., & Kimura, M. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.08.013 · Cited by 302 · see citing works
Di Virgilio, F., Schmalzing, G., & Markwardt, F. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.01.005 · Cited by 279 · see citing works
Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors
Donnelly‐Roberts, D. L., Namovic, M. T., Han, P., & Jarvis, M. F. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00233.x · Cited by 271 · see citing works
Reanalysis of P2X<sub>7</sub>Receptor Expression in Rodent Brain
Sim, J. A., Young, M. T., Sung, H.-Y., North, R. A., & Surprenant, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1469-04.2004 · Cited by 264 · see citing works
Lucae, S., Salyakina, D., Barden, N., Harvey, M., Gagné, B., Labbé, M., Binder, E. B., Uhr, M., Paez-Pereda, M., Sillaber, I., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl166 · Cited by 261 · see citing works
Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor
Adinolfi, E., Cirillo, M., Woltersdorf, R., Falzoni, S., Chiozzi, P., Pellegatti, P., Callegari, M. G., Sandonà, D., Markwárdt, F., Schmalzing, G., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-153601 · Cited by 254 · see citing works
Gene–Environment Interactions in Severe Mental Illness
Uher, R. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00048 · Cited by 251 · see citing works
Stock, T. C., Bloom, B. J., Wei, N., Ishaq, S., Park, W., WANG, X., Gupta, P. K., & MEBUS, C. A. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.110874 · Cited by 246 · see citing works
Basso, A. M., Bratcher, N. A., Harris, R. R., Jarvis, M. F., Decker, M. W., & Rueter, L. E. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.10.018 · Cited by 224 · see citing works
The microglial ATP‐gated ion channel P2X7 as a CNS drug target
Bhattacharya, A., & Biber, K. (2016) · Glia · doi:10.1002/glia.23001 · Cited by 221 · see citing works
Polygenic interactions with environmental adversity in the aetiology of major depressive disorder
Mullins, N., Power, R. A., Fisher, H. L., Hanscombe, K. B., Euesden, J., Iniesta, R., Levinson, D. F., Weissman, M. M., Potash, J. B., Shi, J., et al. (2015) · Psychological Medicine · doi:10.1017/s0033291715002172 · Cited by 210 · see citing works
Emerging challenges of assigning P2X7 receptor function and immunoreactivity in neurons
Anderson, C. M., & Nedergaard, M. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.03.003 · Cited by 207 · see citing works
Barden, N., Harvey, M., Gagné, B., Shink, É., Tremblay, M., Raymond, C., Labbé, M., Villeneuve, A., Rochette, D., Bordeleau, L., et al. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30303 · Cited by 201 · see citing works
The human P2X7 receptor and its role in innate immunity
Wiley, J. S., Sluyter, R., Gu, B. J., Stokes, L., & Fuller, S. J. (2011) · Tissue Antigens · doi:10.1111/j.1399-0039.2011.01780.x · Cited by 198 · see citing works
Engel, T., Gómez‐Villafuertes, R., Tanaka, K., Mesuret, G., Sanz‐Rodriguez, A., García-Huerta, P., Miras‐Portugal, M. T., Henshall, D. C., & Dı́az-Hernández, M. (2011) · The FASEB Journal · doi:10.1096/fj.11-196089 · Cited by 196 · see citing works
Nicke, A., Kuan, Y., Masin, M., Rettinger, J., Marquez-Klaka, B., Bender, O., Górecki, D. C., Murrell‐Lagnado, R. D., & Soto, F. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033134 · Cited by 187 · see citing works
Neuronal P2X7 Receptors Revisited: Do They Really Exist?
Illes, P., Khan, T. M., & Rubini, P. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.3103-16.2017 · Cited by 179 · see citing works
Stokes, L., Fuller, S. J., Sluyter, R., Skarratt, K. K., Gu, B. J., & Wiley, J. S. (2010) · The FASEB Journal · doi:10.1096/fj.09-150862 · Cited by 174 · see citing works
Smart, M. L., Gu, B., Panchal, R. G., Wiley, J., Cromer, B., Williams, D. A., & Petrou, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211094200 · Cited by 170 · see citing works
The P2X7 Receptor-Interleukin-1 Liaison
Giuliani, A. L., Sarti, A. C., Falzoni, S., & Di Virgilio, F. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00123 · Cited by 166 · see citing works
Neuronal P2X7 Receptor: Involvement in Neuronal Physiology and Pathology
Miras‐Portugal, M. T., Sebastián‐Serrano, Á., García, L. D. D., & Dı́az-Hernández, M. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.3104-16.2017 · Cited by 154 · see citing works
Feng, Y., Li, X., Wang, L., Zhou, L., & Gorodeski, G. I. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602999200 · Cited by 152 · see citing works
Molecular and Cellular Mechanisms of Rapid-Acting Antidepressants Ketamine and Scopolamine
Wohleb, E. S., Gerhard, D. M., Thomas, A., & Duman, R. S. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160309114549 · Cited by 151 · see citing works
Ullrich (2018) · doi:10.1038/mp.2017.188 · Cited by 145 · see citing works
The First CNS-Active Carborane: A Novel P2X7 Receptor Antagonist with Antidepressant Activity
Wilkinson, S. M., Gunosewoyo, H., Barron, M. L., Boucher, A. A., McDonnell, M., Turner, P., Morrison, D. E., Bennett, M. R., McGregor, I. S., Rendina, L. M., et al. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500054n · Cited by 143 · see citing works
Lavebratt, C., Åberg, E., Sjöholm, L. K., & Forsell, Y. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.02.113 · Cited by 140 · see citing works
Eser, A., Colombel, J., Rutgeerts, P. J., Vermeire, S., Vogelsang, H., Braddock, M., Persson, T., & Reinisch, W. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000514 · Cited by 138 · see citing works
Roger, S., Mei, Z.-Z., Baldwin, J. M., Dong, L., Bradley, H., Baldwin, S. A., Surprenant, A., & Jiang, L. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.10.005 · Cited by 131 · see citing works
C terminus of the P2X7 receptor: treasure hunting
Costa‐Junior, H. M., Vieira, F. S., & Coutinho‐Silva, R. (2011) · Purinergic Signalling · doi:10.1007/s11302-011-9215-1 · Cited by 128 · see citing works
Csölle, C., Baranyi, M., Zsilla, G., Kittel, Á., Gölöncsér, F., Illes, P., Papp, E., Vizi, E. S., & Sperlágh, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066547 · Cited by 128 · see citing works
Karasawa, A., Michalski, K., Mikhelzon, P., & Kawate, T. (2017) · eLife · doi:10.7554/elife.31186 · Cited by 127 · see citing works
McQuillin, A., Bass, N. J., Choudhury, K., Puri, V., Kosmin, M., Lawrence, J., Curtis, D., & Gurling, H. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.6 · Cited by 117 · see citing works
Recent advances in CNS P2X7 physiology and pharmacology: Focus on neuropsychiatric disorders
Bhattacharya, A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00030 · Cited by 115 · see citing works
Astrocyte-Mediated Ischemic Tolerance
Hirayama, Y., Ikeda‐Matsuo, Y., Notomi, S., Enaida, H., Kinouchi, H., & Koizumi, S. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4218-14.2015 · Cited by 114 · see citing works
Boucher, A. A., Arnold, J. C., Hunt, G. E., Spiro, A., Spencer, J., Brown, C., McGregor, I. S., Bennett, M. R., & Kassiou, M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.05.049 · Cited by 108 · see citing works
Csölle, C., Andó, R. D., Kittel, Á., Gölöncsér, F., Baranyi, M., Soproni, K., Zelena, D., Haller, J., Németh, T., Mócsai, A., et al. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001933 · Cited by 108 · see citing works
Association between depression and the Gln460Arg polymorphism of P2RX7 gene: A dimensional approach
Hejjas, K., Szekely, A., Domotor, E., Halmai, Z., Balogh, G., Schilling, B., Sarosi, A., Faludi, G., Sasvari‐Szekely, M., & Nemoda, Z. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30799 · Cited by 100 · see citing works
Jimenez-Mateos, E. M., Arribas-Blazquez, M., Sanz-Rodriguez, A., Concannon, C., Olivos-Ore, L. A., Reschke, C. R., Mooney, C. M., Mooney, C., Lugara, E., Morgan, J., et al. (2015) · Scientific Reports · doi:10.1038/srep17486 · Cited by 94 · see citing works
Metzger, M. W., Walser, S. M., Aprile-Garcia, F., Dedic, N., Chen, A., Holsboer, F., ARZT, E. S., Wurst, W., & Deussing, J. M. (2016) · Purinergic Signalling · doi:10.1007/s11302-016-9546-z · Cited by 92 · see citing works
Self-citationSoronen, P., Mantere, O., Melartin, T. K., Suominen, K. H., Vuorilehto, M. S., Rytsälä, H. J., Arvilommi, P., Holma, I. A. K., Holma, M., Jylhä, P. J., et al. (2011) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31179 · Cited by 91 · see citing works
ATP and the purine type 2 X7 receptor affect sleep
Krueger, J. M., Taishi, P., De, A., Davis, C. J., Winters, B. D., Clinton, J. M., Szentirmai, É., & Zielinski, M. R. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00586.2010 · Cited by 89 · see citing works
Chen, Y., Molet, J., Gunn, B. G., Ressler, K. J., & Baram, T. Z. (2015) · Endocrinology · doi:10.1210/en.2015-1673 · Cited by 86 · see citing works
Effects of stress across the lifespan
Koenig, J. I., Walker, C., Romeo, R. D., & LUPIEN, S. J. (2011) · Stress · doi:10.3109/10253890.2011.604879 · Cited by 85 · see citing works
Jørgensen, N. R., Husted, L. B., Skarratt, K. K., Stokes, L., Tofteng, C. L., Kvist, T., Jensen, J. B., Eiken, P., Brixen, K., Fuller, S. J., et al. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.253 · Cited by 82 · see citing works
A genome-wide scan points to a susceptibility locus for bipolar disorder on chromosome 12
Shink, E., Morissette, J., Sherrington, R., & Barden, N. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001601 · Cited by 79 · see citing works
P2X7 receptors at adult neural progenitor cells of the mouse subventricular zone
Messemer, N., Kunert, C., Grohmann, M., Sobottka, H., Nieber, K., Zimmermann, H., Franke, H., Nörenberg, W., Straub, I., Schaefer, M., et al. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.017 · Cited by 70 · see citing works
P2RX7: A bipolar and unipolar disorder candidate susceptibility gene?
Green, E., Grozeva, D., Raybould, R., Elvidge, G. P., MacGregor, S., Craig, I., FARMER, A. E., McGuffin, P., Forty, L., Jones, L. A., et al. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30931 · Cited by 66 · see citing works
García-Huerta, P., Dı́az-Hernández, M., Delicado, E. G., Pimentel-Santillana, M., Miras‐Portugal, M. T., & Gómez‐Villafuertes, R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.390971 · Cited by 62 · see citing works
Significance of risk polymorphisms for depression depends on stress exposure
Gonda, X., Hullám, G., Antal, P., Eszlári, N., Petschner, P., Hökfelt, T. G. M., Anderson, I. M., Deakin, J. F. W., Juhász, G., & Bagdy, G. (2018) · Scientific Reports · doi:10.1038/s41598-018-22221-z · Cited by 62 · see citing works
The P2RX7 polymorphism rs2230912 is associated with depression: A meta-analysis
Czamara, D., Müller-Myhsok, B., & Lucae, S. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.11.003 · Cited by 60 · see citing works
Metzger, M. W., Walser, S. M., Dedic, N., Aprile-Garcia, F., Jakubcakova, V., Adamczyk, M., Webb, K. J., Uhr, M., Refojo, D., Schmidt, M. V., et al. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.3487-16.2017 · Cited by 59 · see citing works
Self-citationUnderstanding the role of P2X7 in affective disorders—are glial cells the major players?
Stokes, L., Spencer, S. J., & Jenkins, T. A. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00258 · Cited by 58 · see citing works
Associations between depression severity and purinergic receptor P2RX7 gene polymorphisms
Halmai, Z., Dome, P., Vereczkei, A., Abdul-Rahman, O., Szekely, A., Gonda, X., Faludi, G., Sasvari-Szekely, M., & Nemoda, Z. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.02.033 · Cited by 55 · see citing works
Grigoroiu‐Serbânescu, M., Herms, S., Mühleisen, T. W., Georgi, A., Diaconu, C. C., Strohmaier, J., Czerski, P. M., Hauser, J., Leszczyńska-Rodziewicz, A., Jamra, R. A., et al. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30952 · Cited by 55 · see citing works
Jin, H., Han, J., Resing, D., Liu, H., Yue, X., Miller, R. L., Schoch, K. M., Miller, T. M., Perlmutter, J. S., Egan, T. M., et al. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.12.006 · Cited by 55 · see citing works
Lymphocytes from P2X7-deficient mice exhibit enhanced P2X7 responses
Taylor, S. R. J., González–Begne, M., Sojka, D. K., Richardson, J. C., Sheardown, S. A., Harrison, S. M., Pusey, C. D., Tam, F. W. K., & Elliott, J. I. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0408251 · Cited by 49 · see citing works
Rapid eye movement (REM) sleep: An endophenotype for depression
Modell, S., & Lauer, C. J. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0065-z · Cited by 49 · see citing works
Lack of Association of P2RX7 Gene rs2230912 Polymorphism with Mood Disorders: A Meta-Analysis
Feng, W.-P., Zhang, B., Li, W., & Liu, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088575 · Cited by 48 · see citing works
Backlund, L., Lavebratt, C., Frisén, L., Nikamo, P., Sudic, D. H., Träskman‐Bendz, L., Landén, M., Edman, G., Vawter, M. P., Ösby, U., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043057 · Cited by 41 · see citing works
Yosifova, A., Mushiroda, T., Stoianov, D., Vazharova, R., Dimova, I. I., Karachanak-Yankova, S., Zaharieva, I. T., Milanova, V. K., Madjirova, N., Gerdjikov, I., et al. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.12.021 · Cited by 41 · see citing works
Regulation of innate immunity by extracellular nucleotides.
Gorini, S., Gatta, L., Pontecorvo, L., Vitiello, L., & la Sala, A. (2013) · Europe PMC (PubMed Central) · Cited by 32 · see citing works
Kongsui, R., Beynon, S. B., Johnson, S. J., Mayhew, J., Kuter, P., Nilsson, M., & Walker, F. R. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.05.017 · Cited by 29 · see citing works
Co-Expression of Wild-Type P2X7R with Gln460Arg Variant Alters Receptor Function
Aprile-Garcia, F., Metzger, M. W., Páez-Pereda, M., Stadler, H., Acuña, M., Liberman, A. C., Senin, S. A., Gerez, J., Hoijman, E., Refojo, D., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151862 · Cited by 25 · see citing works
Self-citationTargeted mutagenesis tools for modelling psychiatric disorders
Deussing, J. M. (2013) · Cell and Tissue Research · doi:10.1007/s00441-013-1708-5 · Cited by 18 · see citing works
Self-citationFunctional significance of P2RX7 polymorphisms associated with affective mood disorders
Sluyter, R., Stokes, L., Fuller, S. J., Skarratt, K. K., Gu, B. J., & Wiley, J. S. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.04.013 · Cited by 17 · see citing works
Flagged first, then by citations
2 of the 98 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
From purines to purinergic signalling: molecular functions and human diseases
Huang, Z., Xie, N., Illés, P., Virgilio, F. D., Ulrich, H., Semyanov, A. V., Verkhratsky, A., Sperlágh, B., Yu, S., Huang, C., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00553-z · Cited by 495 · see citing works
Gut Microbiota and Their Neuroinflammatory Implications in Alzheimer’s Disease
Giau, V. V., Wu, S., Jamerlan, A., An, S. S. A., Kim, S., & Hulme, J. (2018) · Nutrients · doi:10.3390/nu10111765 · Cited by 235 · see citing works
Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology
Ribeiro, D. E., Oliveira-Giacomelli, Á., Glaser, T., Arnaud-Sampaio, V. F., Andrejew, R., Dieckmann, L., Baranova, J., Lameu, C., Ratajczak, M. Z., & Ulrich, H. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00965-3 · Cited by 145 · see citing works
P2X7 Receptors Amplify CNS Damage in Neurodegenerative Diseases
Illés, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21175996 · Cited by 141 · see citing works
Mitochondrial dysfunction: A fatal blow in depression
Song, Y., Cao, H., Zuo, C., Gu, Z., Huang, Y., Miao, J., Fu, Y., Guo, Y., Jiang, Y., & Wang, F. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115652 · Cited by 138 · see citing works
P2X7 Receptor Signaling in Stress and Depression
Ribeiro, D. E., Roncalho, A. L., Glaser, T., Ulrich, H., Wegener, G., & Joca, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112778 · Cited by 129 · see citing works
Mitochondria, Microglia, and the Immune System—How Are They Linked in Affective Disorders?
Culmsee, C., Michels, S., Scheu, S., Arolt, V., Dannlowski, U., & Alferink, J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00739 · Cited by 110 · see citing works
The pharmacological properties of chrysophanol, the recent advances
Su, S., Wu, J., Gao, Y., Luo, Y., Yang, D., & Wang, P. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110002 · Cited by 105 · see citing works
Zhang, J., Shen, S.-Y., Zhai, M.-Y., Shen, Z.-Q., Li, W., Liang, L., Yin, S.-Y., Han, Q.-Q., Li, B., Zhang, Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49597-z · Cited by 101 · see citing works
Regulation of P2X7 receptor expression and function in the brain
Jimenez-Mateos, E. M., Smith, J., Nicke, A., & Engel, T. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.12.008 · Cited by 79 · see citing works
Pathological ATPergic Signaling in Major Depression and Bipolar Disorder
Illés, P., Verkhratsky, A., & Tang, Y. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00331 · Cited by 77 · see citing works
Astrocytes and major depression: The purinergic avenue
Zhao, Y. F., Verkhratsky, A., Tang, Y. C., & Illés, P. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109252 · Cited by 73 · see citing works
Purinergic Receptors of the Central Nervous System: Biology, PET Ligands, and Their Applications
Zarrinmayeh, H., & Territo, P. (2020) · Molecular Imaging · doi:10.1177/1536012120927609 · Cited by 63 · see citing works
The role and mechanism of tryptophan – kynurenine metabolic pathway in depression
Gong, X., Chang, R., Zou, J., Tan, S., & Huang, Z. (2022) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0047 · Cited by 69 · see citing works
Pathogenesis of depression and the potential for traditional Chinese medicine treatment
Ding, W., Wang, L., Li, L., Li, H., Wu, J., Zhang, J., & Wang, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1407869 · Cited by 66 · see citing works
Pegoraro, A., Marchi, E. D., & Adinolfi, E. (2021) · Cells · doi:10.3390/cells10010189 · Cited by 63 · see citing works
Memantine Derivatives as Multitarget Agents in Alzheimer’s Disease
Marotta, G., Basagni, F., Rosini, M., & Minarini, A. (2020) · Molecules · doi:10.3390/molecules25174005 · Cited by 61 · see citing works
Structural basis for the functional properties of the P2X7 receptor for extracellular ATP
Jiang, L., Caseley, E. A., Muench, S. P., & Roger, S. (2021) · Purinergic Signalling · doi:10.1007/s11302-021-09790-x · Cited by 61 · see citing works
Guan, S., Shen, Y., Ge, H., Xiong, W., He, L., Liu, L., Yin, C., Wei, X., & Gao, Y. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00770 · Cited by 60 · see citing works
miR-124 ameliorates depressive-like behavior by targeting STAT3 to regulate microglial activation
Lou, D., Wang, J., & Wang, X. (2019) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2019.101470 · Cited by 58 · see citing works
Wang, R., Zhang, Y., Guo, Y., Zeng, W., Li, J., Wu, J. J., Li, N., Zhu, A., Li, J., Di, L., et al. (2023) · Fundamental Research · doi:10.1016/j.fmre.2023.09.007 · Cited by 59 · see citing works
Shen, S., Liang, L., Shi, T., Shen, Z., Yin, S., Zhang, J., Li, W., Mi, W., Wang, Y., Zhang, Y., et al. (2025) · Advanced Science · doi:10.1002/advs.202412556 · Cited by 53 · see citing works
The P2X7 receptor: a new therapeutic target in Alzheimer’s disease
Illés, P., Rubini, P., Huang, L., & Tang, Y. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1575811 · Cited by 49 · see citing works
P2X7R antagonists in chronic stress-based depression models: a review
von Mücke-Heim, I.-A., Ries, C., Urbina-Treviño, L., & Deussing, J. M. (2021) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01306-3 · Cited by 46 · see citing works
Self-citationAhn, Y. H., Tang, Y., & Illés, P. (2023) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2023.2258281 · Cited by 41 · see citing works
Zhao, Y.-F., Ren, W.-J., Zhang, Y., He, J., Yin, H., Liao, Y., Rubini, P., Deussing, J. M., Verkhratsky, A., Yuan, Z., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031904 · Cited by 40 · see citing works
Self-citationNovel Molecular Targets of Antidepressants
Jarończyk, M., & Walory, J. (2022) · Molecules · doi:10.3390/molecules27020533 · Cited by 40 · see citing works
Association of purinergic receptor P2RX7 gene polymorphisms with depression symptoms
Vereczkei, A., Abdul-Rahman, O., Halmai, Z., Nagy, G., Székely, A., Somogyi, A., Faludi, G., & Nemoda, Z. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.01.006 · Cited by 37 · see citing works
To Inhibit or Enhance? Is There a Benefit to Positive Allosteric Modulation of P2X Receptors?
Stokes, L., Bidula, S., Bibic, L., & Allum, E. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00627 · Cited by 34 · see citing works
FTY720 in CNS injuries: Molecular mechanisms and therapeutic potential
Zhang, L., & Wang, H. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.08.013 · Cited by 34 · see citing works
Role of neuroglia in neuropathic pain and depression
Liu, Q., Li, R., Yang, W., Cui, R., & Li, B. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105957 · Cited by 35 · see citing works
Li, X., Wang, H., Li, C., Wu, J., Lü, J., Guo, J., & Tu, Y. (2021) · The Anatomical Record · doi:10.1002/ar.24778 · Cited by 31 · see citing works
Li, Y., Dang, X., Chen, R., Teng, Z., Wang, J., Li, S., Yue, Y., Mitchell, B. L., Zeng, Y., Yao, Y.-G., et al. (2025) · Nature Human Behaviour · doi:10.1038/s41562-024-02073-6 · Cited by 30 · see citing works
Animal Models for the Investigation of P2X7 Receptors
Sluyter, R., Adriouch, S., Fuller, S. J., Nicke, A., Sophocleous, R. A., & Watson, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098225 · Cited by 26 · see citing works
Zhang, R., Su, K., Yang, L., Tang, M., Zhao, M., Ye, N., Cai, X., Jiang, X., Li, N., Peng, J., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00837 · Cited by 26 · see citing works
Beyond Seizure Control: Treating Comorbidities in Epilepsy via Targeting of the P2X7 Receptor
Gil, B., Smith, J., Tang, Y., Illés, P., & Engel, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042380 · Cited by 26 · see citing works
Hou, L., Liu, Y., Zhu, C., Miao, J., Zhou, W., Tang, Y., Meng, H., & Liu, S. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1107781 · Cited by 26 · see citing works
P2X7 Variants in Pathophysiology
Pegoraro, A., Grignolo, M., Ruo, L., Ricci, L., & Adinolfi, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126673 · Cited by 25 · see citing works
Effects of adjunctive inflammatory modulation on IL-1β in treatment resistant bipolar depression
Murata, S., Murphy, M. L. M., Hoppensteadt, D., Fareed, J., Welborn, A., & Halaris, A. E. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.01.004 · Cited by 24 · see citing works
Chen, J., Li, T., Huang, D., Gong, W., Tian, J., Gao, X., Qin, X., Du, G., & Zhou, Y. (2023) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2023.08.008 · Cited by 24 · see citing works
P2X7 receptor-mediated depression-like reactions arising in the mouse medial prefrontal cortex
Ren, W., Zhao, Y.-F., Li, J., Rubini, P., Yuan, Z., Tang, Y., & Illés, P. (2023) · Cerebral Cortex · doi:10.1093/cercor/bhad166 · Cited by 24 · see citing works
Ramírez-Fernández, A., Urbina-Treviño, L., Conte, G., Alves, M., Rissiek, B., Durner, A., Scalbert, N., Zhang, J., Magnus, T. U., Koch‐Nolte, F., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-76428-0 · Cited by 22 · see citing works
Self-citationP2X7 Receptor as a Potential Target for Major Depressive Disorder
Huang, Z., & Tan, S. (2021) · Current Drug Targets · doi:10.2174/1389450122666210120141908 · Cited by 20 · see citing works
P2X7 Receptor-Related Genetic Mouse Models – Tools for Translational Research in Psychiatry
Urbina-Treviño, L., von Mücke-Heim, I.-A., & Deussing, J. M. (2022) · Frontiers in Neural Circuits · doi:10.3389/fncir.2022.876304 · Cited by 22 · see citing works
Self-citationDias, L., Pochmann, D., Lemos, C., Silva, H. B. L., Real, J. I., Gonçalves, F. Q., Rial, D., Gonçalves, N., Simões, A. P., Ferreira, S. G., et al. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00810 · Cited by 21 · see citing works
Tang, Y., Illes, P., Zhang, Y., Yin, H.-Y., & Rubini, P. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220302152400 · Cited by 20 · see citing works
The neurobiological mechanisms and therapeutic prospect of extracellular ATP in depression
Wang, K., Huang, S., Fu, D., Yang, X., Ma, L., Zhang, T., Zhao, W., Deng, D., Ding, Y., Zhang, Y., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14536 · Cited by 19 · see citing works
Silberstein, S., Liberman, A. C., Claro, P. A. D. S., Ugo, M. B., Deussing, J. M., & ARZT, E. S. (2021) · NeuroImmunoModulation · doi:10.1159/000515130 · Cited by 19 · see citing works
Self-citationNeuroprotection of exercise: P2X4R and P2X7R regulate BDNF actions
Sun, B.-X., Peng, A., Liu, P., Wang, M., Ding, H., Hu, Y., & Kang, L. (2022) · Purinergic Signalling · doi:10.1007/s11302-022-09879-x · Cited by 19 · see citing works
The P2X7 receptor in mood disorders: Emerging target in immunopsychiatry, from bench to bedside
von Mücke-Heim, I.-A., & Deussing, J. M. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109366 · Cited by 18 · see citing works
Self-citationBhatane, D., Pamshong, S. R., Sarnaik, S., Prabakaran, A., & Alexander, A. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104970 · Cited by 17 · see citing works
Akçay, E., & Karataş, H. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100853 · Cited by 18 · see citing works
Recent Advances in the Development of Antidepressants Targeting the Purinergic P2X7 Receptor
Lee, S., Ha, H., Jang, J., & Byun, Y. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220629141418 · Cited by 16 · see citing works
Kristóf, Z., Eszlári, N., Sütöri, S., Gál, Z., Török, D., Baksa, D., Petschner, P., Sperlágh, B., Anderson, I. M., Deakin, J. F. W., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252766 · Cited by 16 · see citing works
Daniels, S. D., & Boison, D. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109756 · Cited by 15 · see citing works
von Mücke-Heim, I.-A., Martin, J. N., Uhr, M., Ries, C., & Deussing, J. M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1148190 · Cited by 13 · see citing works
Self-citationHou, L., Miao, J., Meng, H., Liu, X., Wang, D., Tan, Y., & Li, C. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.855810 · Cited by 11 · see citing works
P2X7 receptor: a potential target for treating comorbid anxiety and depression
Liu, J. H., Liu, T.-T., Mou, L., Zhang, Y., Chen, X., Wang, Q., Deng, B.-L., & Liu, J. (2024) · Purinergic Signalling · doi:10.1007/s11302-024-10007-0 · Cited by 10 · see citing works
Schäfer, W., Stähler, T., Pinto-Espinoza, C., Danquah, W., Knop, J., Rissiek, B., Haag, F., & Koch‐Nolte, F. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1033135 · Cited by 10 · see citing works
Antidepressant Drug Discovery and Development: Mechanism and Drug Design Based on Small Molecules
Yao, C., Jiang, X., Ye, X., Xie, T., & Bai, R. (2022) · Advanced Therapeutics · doi:10.1002/adtp.202200007 · Cited by 10 · see citing works
Ren, X.-Y., Rubini, P., Engel, T., Tang, Y., & Illés, P. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107989 · Cited by 9 · see citing works
Zhang, Z., Guo, H., Hu, Z., Zhou, C., Hu, Q., Peng, H. Y., Tang, G., Xiao, Z., Pi, L., & Li, G. (2023) · Disease Markers · doi:10.1155/2023/9956950 · Cited by 9 · see citing works
Wang, Y., Chen, C.-Y., Yang, X., Lei, L., & Zhang, Y. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111566 · Cited by 8 · see citing works
Shuang, R., Gao, T., Sun, Z., Tong, Y. A., Zhao, K., & Wang, H. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176417 · Cited by 8 · see citing works
Targeting calciumopathy for neuroprotection: focus on calcium channels Cav1, Orai1 and P2X7
Torres-Rico, M., García-Calvo, V., Gironda-Martínez, A., Pascual-Guerra, J., Garcı́a, A. G., & Maneu, V. (2024) · Cell Calcium · doi:10.1016/j.ceca.2024.102928 · Cited by 7 · see citing works
Neuroprotective effects of macrostemonoside T on glutamate-induced injury in HT22 cells
Ding, W., Wang, L., Wu, J., Li, H., Li, B., Wang, Y., Zhang, J., & Li, W. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116827 · Cited by 7 · see citing works
Smith, K. L., Todd, S. M., Boucher, A. A., Bennett, M. R., & Arnold, J. C. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134575 · Cited by 7 · see citing works
Kong, Y., Wang, Q., Wu, D., Hu, J., Zang, W., Li, X., Yang, J., & Gao, T. (2020) · Genes Brain & Behavior · doi:10.1111/gbb.12691 · Cited by 7 · see citing works
Sander, S., Müller, I., García-Alai, M., Nicke, A., & Tidow, H. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102495 · Cited by 7 · see citing works
von Mücke-Heim, I.-A., Oldekamp, J., Metzger, M. W., Kläffgen, S., Tang, H., Walser, S. M., Dedic, N., Rammes, G., Holsboer, F., Wurst, W., et al. (2025) · Purinergic Signalling · doi:10.1007/s11302-025-10074-x · Cited by 4 · see citing works
Self-citationKristóf, Z., Szabó, D., Sperlágh, B., Török, D., & Gonda, X. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104687 · Cited by 5 · see citing works
Fülöp, Z., Bana, P., Greiner, I., & Éles, J. (2025) · RSC Advances · doi:10.1039/d5ra03780h · Cited by 4 · see citing works
Zhang, L., Verwer, R. W. H., van Heerikhuize, J. J., Balesar, R. A., Corrêa‐da‐Silva, F., Slabe, Z., Lucassen, P. J., & Swaab, D. F. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.22.516142 · Cited by 4 · see citing works
Ding, W., Sun, Y., Wu, J., Li, H., Wang, Z., Li, W., Shi, L.-L., Zhang, J., & Wang, L. (2025) · Journal of Food Biochemistry · doi:10.1155/jfbc/8113079 · Cited by 3 · see citing works
Monaco, S., Browne, J., Wallace, M., Angulo, J., & Stokes, L. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c02985 · Cited by 3 · see citing works
Purinergic receptor (P2X7R): A Promising Anti-Parkinson's Drug Target
Varshini, M. S., M, L., Krishnamurthy, P. T., Shaji, N., & Reddy, R. A. (2024) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.43206 · Cited by 3 · see citing works
Cell Type-Specific Expression of Purinergic P2X Receptors in the Hypothalamus
Cihakova, J., Ivetic, M., & Zemkova, H. W. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115007 · Cited by 3 · see citing works
He, X.-M., Zhang, Y., Chen, C.-Y., Tang, Y.-L. H., & Li, X. (2026) · Purinergic Signalling · doi:10.1007/s11302-026-10150-w · Cited by 2 · see citing works
Wu, X., Guo, C., Wang, S., Gong, T., Yao, J., Hu, L., Deng, Z., Tang, L. Y., Xie, P., Zhang, Z., et al. (2025) · Chemical Biology & Drug Design · doi:10.1111/cbdd.70048 · Cited by 2 · see citing works
Purinergic Regulation of Neuroinflammation in Traumatic Brain Injury
Serebryanaya, N. B., Fomicheva, E. E., & Павлович, Я. П. (2022) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-022-01337-w · Cited by 1 · see citing works
Chen, L.-Q., Lv, X., Guo, Q.-H., Lv, S.-S., Lv, N., Yu, J., Xu, W., & Zhang, Y.-Q. (2022) · bioRxiv · doi:10.1101/2022.04.16.488241 · Cited by 2 · see citing works
Der Mensch beeinflusst seine Biologie – wie Weltbilder die Zukunft formen
Gründer, G. (2020) · Springer eBooks · doi:10.1007/978-3-662-61713-7_7
Formularity and Formal Structure in the Old Beneventan Chant
Bereza, S. (2011) · OhioLink ETD Center (Ohio Library and Information Network)
Enikeeva, R. F., Kazantseva, A. V., Давыдова, Ю. Д., Mustafin, R. N., Takhirova, Z., Lobaskova, M. M., Mikhailova, A. K., Федореева, К., Malykh, S. B., & Хуснутдинова, Э. К. (2021) · Modern Issues of Biochemistry, Genetics and Biotechnology · doi:10.33184/spbgb-2021-09-21.17
Man Influences His Biology: How World Views Shape the Future
Gründer, G. (2022) · Springer eBooks · doi:10.1007/978-3-662-64225-2_7
Ding, W., Wang, L., Li, H., Li, B., Wu, J., Wang, Y., Zhang, J., & Li, W. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.5013120
Zheng, S., Guo, J., Zheng, R., Ji, Y., Zhong, Q., & Yin, H. (2025) · Depression and Anxiety · doi:10.1155/da/8124403
Monaco, S., Browne, J., Wallace, M., Angulo, J., & Stokes, L. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.22.649959
Ponnusamy, G., & Mythili, C. (2025) · Indian Journal of Medical Biochemistry · doi:10.5005/jp-journals-10054-0253
Zhu, L., Mao, Q., Luo, Z., Chen, B., ZHANG, Y., Lu, X., Liu, P., Ji, J., Wang, X., Wang, K., et al. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121327
Extracellular ATP in psychiatric disorders
von Mücke-Heim, I.-A., & Deussing, J. M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-30250-3.00015-1
Self-citationIn vitro and in vivo study of the effects of Levetiracetam on activated microglia during sepsis
Fleurance, R. (2021) · theses.fr (ABES) · doi:10.70675/0a82ed6ez6595z4366z832fz70cbe839c7ff
Ding, W., MingZe, L., Liu, L., Zhang, L., Li, H., Dong, R., Li, W., Zhang, J., & Wang, L. (2026) · Journal of Functional Foods · doi:10.1016/j.jff.2026.107319
Wang, B., Huang, Y., Yang, W., Xu, N., Li, Y., Du, C., Zhang, X., Wang, H., & Lou, H. (2026) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2026.111931
Zhang, L., Heimel, J. A., & Swaab, D. F. (2026) · The British Journal of Psychiatry · doi:10.1192/bjp.2026.10717
- Authors
- Deussing, J. M., & Arzt, E.
- Affiliations
- Max Planck Institute of Psychiatry (DE)
- Max Planck Society (DE)
- Corresponding author
- Deussing, Jan M.
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 24
- Issue
- 9
- Pages
- 736-747
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W2885132844
- Cited by
- 97
- References
- 98
- Citations by year
- 2026: 6 · 2025: 15 · 2024: 11 · 2023: 13 · 2022: 18 · 2021: 11 · 2020: 12 · 2019: 7 · 2018: 3
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Trends in Molecular Medicine (publishedVersion)
- PubMed (publishedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Conicet (submittedVersion, cc-by-nc-nd)
- Funders
- Bundesministerium für Bildung und Forschung (FKZ 01ZX1314H)
- Consejo Nacional de Investigaciones Científicas y Técnicas
- Agencia Nacional de Promoción Científica y Tecnológica
- Max-Planck-Gesellschaft
- Universidad de Buenos Aires
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Keywords
- P2X7 receptor, depression, therapeutic target, inflammatory signaling, inflammatory cytokines, IL-1β, genetic risk factors, bipolar disorder, pharmacotherapy
- MeSH terms
- Animals, Depression, Depressive Disorder, Humans, Inflammation, Cytokines, Mutation, Missense, Polymorphism, Single Nucleotide, Drug Discovery, Receptors, Purinergic P2X7, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review